Download Cancer in Illinois 2013 - Illinois Department of Public Health

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Illinois State Capitol Building and Complex
Who We Are
What We Do
The Illinois State Cancer Registry is the
only source of population‐based cancer
information in Illinois.
The Illinois State Cancer Registry is a program within the Illinois Department
of Public Health’s Division of Epidemiologic Studies and was created in 1986
by the Illinois Health and Hazardous Substances Registry Act. The cancer
registry has a staff of 12 plus a registry manager.
Cancer registry staff have 143 years of
combined experience as certified tumor
registrars.
The registry collects information on cancer cases diagnosed or treated in
Illinois. Hospitals, ambulatory surgical treatment centers, non‐hospital
affiliated radiation therapy treatment centers, independent pathology labs, and
physicians are required to report to the registry. Eleven other state cancer
registries voluntarily report cancer patient data for Illinois residents who are
diagnosed and/or treated out of state.
Cancer information is collected by certified tumor registrars who have
successfully completed the training and passed the examination required by
the National Cancer Registrar’s Association. Ongoing continuing education is
required to maintain certification. The registry has staff with years of service as
cancer registrars. These legacy employees are one reason the Illinois State
Cancer Registry has achieved “Gold Certification,” the highest level, from the
North American Association of Central Cancer Registries for the past 15 years.
All information about the patient and the facility that reported the cancer is
kept confidential.
What is cancer incidence?
A cancer incidence rate is the number of new cancers of a specific site/type
occurring in a specified population during a year, usually expressed as the
number of cancers per 100,000 population at risk. That is,
Incidence rate = (New cancers/Population) × 100,000
The numerator of the incidence rate is the number of new cancers; the
denominator is the size of the population. The number of new cancers may
include multiple primary cancers occurring in one patient. The primary site
reported is the site of origin and not the metastatic site. In general, the
incidence rate would not include recurrences. The population used depends
on the rate to be calculated. For cancer sites that occur in only one sex, the
sex‐specific population (e.g., females for cervical cancer) is used.
For a cancer case to be complete it
must have information about the
person (where they were born, marital
status, age, where they live),
information on the type of cancer and
its treatment.
An age‐adjusted rate is a weighted average of the age‐specific rates, where the
weights are the proportions of persons in the corresponding age groups of a
standard population. The potential confounding effect of age is reduced when
comparing age-adjusted rates computed using the same standard population.
— www.cancer.gov
What is cancer mortality?
A cancer mortality rate is the number of deaths, with cancer as the underlying
cause of death, occurring in a specified population during a year. Cancer
mortality is usually expressed as the number of deaths due to cancer per
100,000 population. That is,
To determine a cancer rate, researchers
must have the population
characteristics of the area. This is
usually obtained from the U.S. Census.
Mortality Rate = (Cancer Deaths/Population) × 100,000
The numerator of the mortality rate is the number of deaths; the denominator
is the size of the population. The population used depends on the rate to be
calculated. For cancer sites that occur in only one sex, the sex‐specific
population (e.g., females for cervical cancer) is used. The mortality rate can be
computed for a given cancer site or for all cancers combined.
— www.cancer.gov
Cancer in Illinois 2013 Illinois Department of Public Health
1
Why is it important to collect cancer
information?
The Illinois State Cancer Registry is one of 50 state central cancer registries in
the United States. All central cancer registries share the same common
activities and purposes. Most central cancer registries in the U.S. funnel data
(but not personal identifiers) into a national cancer data base maintained by
the U.S. Centers for Disease Control and Prevention.
Cancer data collection by central cancer registries is also called cancer
surveillance. Cancer data are the eyes used to see the impact of cancer, trends
in various populations, patterns of occurrence and much more.
n Doctors and researchers use cancer data to learn more about
the causes of cancer.
n Doctors and researchers use cancer data to learn how to detect
cancers earlier, when they are more treatable.
n Cancer specialists make treatment choices based on accurate
cancer data.
n Cancer data may point to environmental risk factors or high
risk behaviors.
n Cancer data may be used to make important public health
decisions about where to direct funds or where to implement
screening programs.
n Cancer data may be used to show whether programs aimed at
modifying risky behavior or increasing screening for people
who are at risk are effective.
n Cancer data may be used to advance clinical, epidemiologic
and health services research.
n Cancer data may be used to determine what present and future
resources are needed in a specific area; these could be medical
resources, such as physicians, cancer specialists, hospitals or
other types of social services, or support services such as
patient transport.
The dome of the Illinois State Capitol
Every day in Illinois…….
n
173
people are diagnosed with cancer
n
65
people die from cancer‐related causes
n
25
women are diagnosed with breast cancer
n
22
men are diagnosed with prostate cancer
n
17
people are diagnosed with colorectal cancer
n
24
people are diagnosed with lung cancer
Cancer is the second leading cause of
death among Americans.
Cancer surveillance activities have
been used to develop effective
strategies to reduce cancer deaths and
strategies for preventing new cases of
cancer that include behavioral and
environmental changes for some
cancer types.
Cancer in Illinois 2013 Illinois Department of Public Health
3
Top 10 Cancers in Men–2010
Top 10 Cancer Cases in Men
Type of Cancer
Rock River Valley
Epidemiology is the study of the
distribution and causes of diseases in
human populations. It is concerned
with the frequency and type of illness
in groups of people, not individuals.
Rate (per 100,000)
Percent of Total
127.0
25.4%
Lung and Bronchus
79.7
14.7%
Colon and Rectum
54.8
10.3%
Urinary Bladder
37.6
6.7%
Non‐Hodgkin Lymphoma
24.3
4.5%
Kidney and Renal Pelvis
21.7
4.3%
Melanoma of the Skin
21.1
4.0%
Oral Cavity and Pharynx
17.0
3.5%
Leukemia
16.7
3.1%
Pancreas
14.7
2.7%
Prostate
Illinois Department of Public Health, Illinois State Cancer Registry, public data file, data as of November 2012.
Top 10 Cancer Deaths in Men
Type of Cancer
Central cancer registries collect data
on all cancer cases within a defined
population such as a state or region.
Rate (per 100,000)
Percent of Total
Lung and Bronchus
62.1
29.3%
Prostate
22.6
9.6%
Colon and Rectum
20.1
9.5%
Pancreas
13.0
6.1%
Leukemia
9.9
4.4%
Esophagus
7.9
3.9%
Non‐Hodgkin Lymphoma
8.3
3.8%
Liver
6.9
3.4%
Bladder
7.6
3.3%
Kidney
5.4
2.6%
U.S. Centers for Disease Control and Prevention, National Center for Health Statistics, released April 2013
4
ILLINOIS STATE CANCER REgISTRy
Top 10 Cancers in Women–2010
Top 10 Cancer Cases in Women
Type of Cancer
Rate (per 100,000)
Percent of Total
Lung and Bronchus
58.4
13.8%
Colon and Rectum
39.1
9.5%
Corpus and Uterus
28.2
6.7%
Thyroid
19.4
4.1%
Non‐Hodgkin Lymphoma
16.3
3.8%
Melanoma of the Skin
13.3
3.0%
Ovary
12.0
2.8%
Pancreas
11.2
2.7%
Kidney and Renal Pelvis
11.7
2.7%
Cancer data in Illinois is collected in a
standard format so it can be compiled
with other state registries to form a
national database of cancer data.
Illinois Department of Public Health, Illinois State Cancer Registry, public data file, data as of November 2012.
Top 10 Cancer Deaths in Women
Type of Cancer
Rate (per 100,000)
Percent of Total
Lung and Bronchus
41.2
26.1%
Breast
22.6
14.7%
Colon and Rectum
14.3
9.6%
Pancreas
10.2
6.7%
Ovary
7.8
5.0%
Leukemia
5.6
3.7%
Corpus and Uterus
5.3
3.4%
Non‐Hodgkin Lymphoma
4.8
3.2%
Brain and Nervous System
3.3
2.0%
Kidney
2.9
1.9%
Each year Illinois cancer registry staff
process about 80,000 cancer reports
for about 65,000 cancer patients
U.S. Centers for Disease Control and Prevention, National Center for Health Statistics, released April 2013
Cancer in Illinois 2013 Illinois Department of Public Health
5
Colorectal Cancer in Illinois
Colorectal cancer (CRC) is currently the third most commonly diagnosed
cancer in the state of Illinois for both men and women and all races, representing
9.9% of all cancer diagnosed in 2010. It is the second most common cause of
cancer‐related deaths, causing 9.5% of cancer deaths in 2010. Colorectal cancer
can affect organs that include the colon, rectum, and appendix. There is no
exact cause known for CRC, but several risk factors have been identified. They
include:
n Age – most cases occur after age 50
n Personal or family history of CRC or polyps
n Conditions that cause inflammation of the colon
n Diet high in fat and low in calcium, folate, and fiber
n Obesity
n Physical inactivity
n Long‐term smoking
n Heavy alcohol consumption
What is the Colon and Rectum?
The colon and rectum are parts of the digestive system, which is also called the
gastrointestinal (GI) system. The first part of the digestive system (the stomach
and small intestine) processes food for energy while the last part (the colon and
rectum) absorbs fluid to form solid waste (fecal matter or stool) that then passes
from the body.
The small intestine joins the large intestine (or large bowel) in the right lower
abdomen. Most of the large intestine is made up of the colon, a muscular tube
about 5 feet long. The colon absorbs water and salt from food matter and serves
as a storage place for waste matter.
The rectum is the final 6 inches of the digestive system. Waste matter goes into
the rectum where it is stored until it passes out of the body through the anus.
Regular colorectal cancer screening is one of the most powerful weapons for
preventing colorectal cancer. Screening is the process of looking for cancer or
precancer in people who have no symptoms of the disease.
— American Cancer Society
6
ILLINOIS STATE CANCER REgISTRy
What Kind of Tests are Done to Find Colorectal Cancer?
Colonoscopy: For this test, the doctor looks at the entire length of the colon
and rectum with a colonoscope. The colonoscope has a video camera on the
end that is connected to a display monitor so the doctor can see and examine
the inside of the colon. Special instruments can be passed through the
colonoscope to remove any suspicious-looking areas such as polyps, if
needed.
Virtual colonoscopy: This test is an advanced type of computed tomography
(CT or CAT) scan of the colon and rectum. A CT scan is an x-ray test that
produces detailed cross-sectional images of your body.
Stool occult blood testing: This test is used to find occult blood (blood that
can’t be seen with the naked eye) in feces.
Sigmoidoscopy: During this test, the doctor looks at part of the colon and
rectum with a sigmoidoscope—a flexible, lighted tube about the thickness of
a finger with a small video camera on the end.
— American Cancer Society
Are We Getting Screened?
Prevention and control of colorectal cancer focuses on screenings, which include
colonoscopies, sigmoidoscopies, and blood stool tests for people older than 50
years of age. The U.S. Preventive Services Task Force recommends the following:
n sigmoidoscopies should be done every five
years,
n colonoscopies should be done every 10 years,
and
n blood stool tests should be done every year.
Colorectal Cancer Screening Prevalence
Illinois, 2002-2010
70.00%
60.00%
50.00%
You should check with your doctor to see if you need to
schedule one of these life‐saving preventive procedures.
40.00%
30.00%
20.00%
10.00%
0.00%
2002
2003
2004
2005* 2006
Had Colon/Sigmoidoscopy (Ages 50+)
2007*
2008 2009*
2010
Had Blood Stool Test (Ages 50+)
Source: Illinois Behavioral Risk Factor Surveillance System (BRFSS), 2000-2010. Illinois Department of Public Health
* Note: Years with an asterisk represent a year when the specific question was omitted in the BRFSS survey for that year.
Data from the Illinois Behavioral Risk Factor
Surveillance System (BRFSS) showed that in 2010,
61.7 percent of people in Illinois reported ever having
a colonoscopy or sigmoidoscopy. This percent has
increased steadily since 2002. However, the percent
of Illinois residents ever having a blood stool test has
decreased since 2002; 34 percent of residents
reported having this test.
Cancer in Illinois 2013 Illinois Department of Public Health
7
Colorectal Cancer Cases in Illinois
JO DAVIESS
STEPHENSON
46.65
41.30
Age-adjusted Colorectal
Cancer Incidence Rates,
All Races, Both Genders,
2006-2010, Illinois
WINNEBAGO BOONE
CARROLL
OGLE
58.32
51.89
LEE
49.13
54.86
DE KALB
KANE
51.05
44.73
445
53.00
GRUNDY
51.12
58.11
55.21
53.29
52.99
KANKAKEE
MARSHALL
49.06
KNOX
WARREN
56.78
51.70
LIVINGSTON
PEORIA
WOODFORD
50.85
42.91
50.90
IROQUOIS
53.08
FULTON
HANCOCK
MCDONOUGH
62.64
53.83
61.95
TAZEWELL
MCLEAN
FORD
49.45
45.71
53.52
MASON
62.44
SCHUYLER
41.85
ADAMS
51.58
CASS
56.16
63.45
PIKE
SCOTT
53.84
48.14
41.40
PIATT
57.54
29.39
MACON
MORGAN
SANGAMON
53.98
52.69
53.22
DOUGLAS
58.07
MOULTRIE
40.89
CHRISTIAN
55.69
SHELBY
59.55
53.03
62.15
63.65
BOND
FAYETTE
EFFINGHAM
JASPER
52.91
52.32
41.76
CRAWFORD
82.61
63.73
MADISON
52.97
CLAY
ST. CLAIR
CLINTON
MARION
61.09
49.95
58.16
RICHLAND LAWRENCE
53.95
65.57
47.75
41.13
JEFFERSON
PERRY
RANDOLPH
53.71
51.47
53.16
EDWARDS
46.50
55.62
HAMILTON
WHITE
73.97
54.46
WILLIAMSON
SALINE
GALLATIN
52.50
64.53
FRANKLIN
51.95
JACKSON
54.87
UNION
JOHNSON
49.83
ALEXANDER PULASKI
70.17
Source: Illinois Department of Public Health, Illinois State Cancer Registry, data as of November 2012.
77.11
HARDIN
42.96
55.97
POPE
MASSAC
53.87
62.19
WABASH
WAYNE
WASHINGTON
MONROE
significantly higher than Illinois rate
not significantly different than Illinois rate
significantly lower than Illinois rate
count not sufficient to produce stable rating
56.15
CUMBERLAND
MONTGOMERY
JERSEY
51.99
CLARK
48.59
MACOUPIN
CALHOUN
Illinois Rate 50.21
EDGAR
54.59
COLES
59.27
GREENE
48.29
54.30
CHAMPAIGN
59.05
65.51
MENARD
BROWN
VERMILION
DE WITT
LOGAN
41.01
ILLINOIS STATE CANCER REgISTRy
3,415
52.44
PUTNAM
STARK
8
COOK
WILL
LA SALLE
55.10
46.29
n
n
n
n
DU PAGE
51.47
BUREAU
HENRY
MERCER
The Illinois age‐adjusted colorectal
cancer incidence rate for both genders
and all races from 2006‐2010 was
50.21 cases per 100,000. Nine
counties across Illinois had incidence
rates that were significantly higher
than the rate for Illinois, and seven
counties had rates that were
significantly lower. Counties with the
highest incidence rates include
Crawford, gallatin and Hamilton.
41.79
KENDALL
52.04
HENDERSON
LAKE
47.48
42.35
WHITESIDE
ROCK ISLAND
Illinois County Map – Incidence Rates
MC HENRY
50.65
45.66
Colorectal Cancer Deaths in Illinois
JO DAVIESS
STEPHENSON
21.44
14.63
Age-adjusted Colorectal
Cancer Mortality Rates,
All Races, Both Genders,
2006-2010, Illinois
WINNEBAGO BOONE
CARROLL
OGLE
18.56
17.09
MC HENRY
LAKE
17.08
14.39
15.32
16.01
DE KALB
KANE
19.20
15.54
DU PAGE
14.62
WHITESIDE
LEE
13.61
22.04
KENDALL
ROCK ISLAND
13.99
BUREAU
HENRY
18.31
19.03
WILL
LA SALLE
22.37
18.04
22.35
GRUNDY
MERCER
19.62
PUTNAM
KANKAKEE
STARK
Illinois County Map – Mortality Rates
The age‐adjusted colorectal cancer
mortality rate for both genders and all
races in Illinois was 18.1 per 100,000
for 2006‐2010. Five counties showed
rates that were significantly higher
than that for Illinois, and five counties
had significantly lower rates. Illinois
counties with the highest mortality
rates include Hamilton, Clinton and
Saline.
19.19
MARSHALL
KNOX
WARREN
HENDERSON
LIVINGSTON
19.13
16.11
PEORIA
WOODFORD
17.42
11.23
17.64
IROQUOIS
14.30
FULTON
HANCOCK
MCDONOUGH
23.45
17.18
18.15
TAZEWELL
MCLEAN
FORD
17.95
17.58
19.57
MASON
15.52
SCHUYLER
20.47
MACON
MORGAN
SANGAMON
17.62
19.08
SCOTT
PIKE
11.84
PIATT
19.12
20.96
DOUGLAS
16.29
15.91
MOULTRIE
22.62
CHRISTIAN
18.98
SHELBY
25.01
22.65
21.71
CUMBERLAND
MONTGOMERY
23.02
14.28
BOND
FAYETTE
EFFINGHAM
13.04
20.08
JASPER
CRAWFORD
23.51
22.84
MADISON
18.40
CLAY
ST. CLAIR
18.85
CLARK
19.40
MACOUPIN
JERSEY
CLINTON
MARION
27.12
20.53
23.94
RICHLAND LAWRENCE
22.00
18.42
20.76
17.59
JEFFERSON
HAMILTON
WHITE
33.17
26.40
WILLIAMSON
SALINE
GALLATIN
19.35
26.54
UNION
JOHNSON
POPE
18.56
24.24
15.77
18.04
EDWARDS
17.63
PERRY
RANDOLPH
17.09
WABASH
WAYNE
WASHINGTON
MONROE
significantly higher than Illinois rate
not significantly different than Illinois rate
significantly lower than Illinois rate
count not sufficient to produce stable rating
EDGAR
20.00
COLES
18.41
GREENE
Illinois Rate 18.1
19.72
CHAMPAIGN
18.74
CASS
BROWN
16.55
VERMILION
DE WITT
LOGAN
MENARD
ADAMS
CALHOUN
n
n
n
n
COOK
19.18
FRANKLIN
20.90
JACKSON
17.81
ALEXANDER PULASKI
HARDIN
MASSAC
17.59
Source: Underlying mortality data provided by NCHS (www.cdc.gov/nchs). Data released April 2013.
Cancer in Illinois 2013 Illinois Department of Public Health
9
Cancer Projections
Did you know there is a world‐wide
shortage of certified tumor registrars?
More information about this
rewarding career can be found at
www.ncra‐usa.org.
JO DAVIESS
STEPHENSON
155
270
WINNEBAGO BOONE
CARROLL
OGLE
110
305
WHITESIDE
LEE
370
230
MC HENRY
LAKE
1,590
3,515
280
1,635
DE KALB
KANE
440
2,265
DU PAGE
4,905
COOK
25,965
KENDALL
ROCK ISLAND
HENRY
925
340
3,415
780
GRUNDY
270
PUTNAM
105
MCDONOUGH
135
175
LIVINGSTON
PEORIA
WOODFORD
270
270
55
HANCOCK
90
335
95
650
MARSHALL
35
KNOX
KANKAKEE
45
STARK
WARREN
WILL
LA SALLE
235
MERCER
HENDERSON
445
BUREAU
245
IROQUOIS
205
FULTON
TAZEWELL
MCLEAN
FORD
265
880
780
100
MASON
110
SCHUYLER
ADAMS
410
According to the National Cancer
Institute, cancer care cost the United
States an estimated $125 billion in
2010 and costs are expected to rise to
at least $158 billion by 2020.
45
CASS
40
75
PIKE
790
90
315
CALHOUN
MADISON
1,595
This map shows the
number of cancer
cases projected for
each county for 2014.
70
BOND
FAYETTE
EFFINGHAM
JASPER
130
215
60
110
CLAY
RANDOLPH
200
Source: Incidence projections were derived from cancer
incidence data from the Illinois Department of Public Health,
Illinois State Cancer Registry, data as of November 2012.
150
120
WABASH
WAYNE
105
EDWARDS
JEFFERSON
45
265
PERRY
135
HAMILTON
WHITE
55
105
FRANKLIN
280
JACKSON
WILLIAMSON
270
SALINE
GALLATIN
270
270
435
HARDIN
UNION
JOHNSON
POPE
110
85
25
PULASKI
ALEXANDER
55
95
280
230
90
190
CRAWFORD
RICHLAND LAWRENCE
100
MARION
WASHINGTON
MONROE
110
CUMBERLAND
1,450
In 2014, Illinois expects a total
of 66,190 cancer cases.
ILLINOIS STATE CANCER REgISTRy
CLARK
145
MONTGOMERY
CLINTON
ST. CLAIR
130
280
205
JERSEY
EDGAR
COLES
SHELBY
MACOUPIN
135
10
90
CHRISTIAN
GREENE
120
MOULTRIE
245
35
DOUGLAS
1,135
30
95
105
MACON
SANGAMON
230
SCOTT
545
860
PIATT
75
MORGAN
VERMILION
CHAMPAIGN
110
175
MENARD
BROWN
DE WITT
LOGAN
40
MASSAC
110
25
80
Research Projects
The Illinois State Cancer Registry has a long history of participating in valuable
research through data sets or data linkages. When the registry is contacted to
provide data or linkages for studies, an extensive process is used to guarantee
that patient confidentiality is protected. Part of this process is review and
approval from an institutional review board (IRB). An IRB ensures that research
is conducted in accordance with rules outlined by the Code of Federal
Regulations, which governs human subjects research and is designed to protect
patients. A few of the studies that the registry participated in are listed below.
Several of these studies have been ongoing for many years and have contributed
significantly to our knowledge about cancer.
Black Women’s Health Study
Black women are more likely to develop certain health problems than white
women. Until the 1990s, most of the studies of women’s health included only
small numbers of black women or none at all. Improving the health of black
women required more knowledge of the causes of these health problems and
also more knowledge about how women stay healthy. More knowledge meant
more research. The BWHS was begun in 1995 to play a key role in carrying
out this research.
The cancer registry receives funding
from the State of Illinois general
revenue fund, from the U.S. Centers
for Disease Control and Prevention’s
National Program of Cancer Registries
and from researchers who use cancer
data.
The BWHS gathers information on many conditions that affect black women
including breast cancer, lupus, premature birth, hypertension, colon cancer,
diabetes, and uterine fibroids. The BWHS is a “follow‐up” study, following the
59,000 women who enrolled in 1995 over time. When the participants entered
the study, they provided information on factors that might influence health
and disease, such as contraceptive use, cigarette smoking, and diet. At regular
intervals, participants provide updated information on these factors and on
any illnesses they develop. www.bu.edu.bwhs/history
Cancer in Illinois 2013 Illinois Department of Public Health
11
Cancer Among U.S. Firefighters
In 2010, the National Institute of Occupational Safety and Health (NIOSH),
with funding assistance from the U.S. Fire Administration, launched a
multi‐year study to examine whether firefighters have a higher risk of cancer
and other causes of death due to job exposures. It is the largest study of U.S.
firefighters ever undertaken and both non‐white and female firefighters are
represented. www.cdc.gov/niosh/firefighters/cii07.html
The 13 employees of the Illinois State
Cancer Registry have 187 combined
years of experience with the Illinois
Department of Public Health.
The Nurses’ Health Study I and The Nurses’ Health Study II
These two studies are among the largest and longest running investigations of
factors that influence women’s health. Started in 1976 and expanded in 1989,
the information provided by the 238,000 dedicated nurse‐participants has led
to many new insights on health and disease. While the prevention of cancer is
still a primary focus, the study also has produced landmark data on
cardiovascular disease, diabetes and many other conditions. Most importantly,
these studies have shown that diet, physical activity and other lifestyle factors
can powerfully promote better health. These studies are funded by the
National Institutes of Health. www.channing.harvard.edu/nhs
The Health Professionals Follow‐up Study
The Illinois State Cancer Registry has
been certified as a “gold Registry” for
the past 15 years. gold certification is
the highest level and cancer data must
meet strict guidelines for quality,
completeness and timeliness to
qualify.
The Health Professionals Follow‐Up Study (HPFS) began in 1986. The
purpose of the study is to evaluate a series of hypotheses about men’s health
relating nutritional factors to the incidence of serious illnesses, such as cancer,
heart disease, and other vascular diseases. This all‐male study is sponsored by
the Harvard School of Public Health and is funded by the National Cancer
Institute. www.hsph.harvard.edu/hpfs
Cancer Prevention Study II (CPS II)
The Cancer Prevention Study II (CPS‐II), which began in 1982, is a prospective
mortality study of approximately 1.2 million American men and women. The
registry participates in the subset CPS‐II Nutrition Survey. The CPS‐II Nutrition
12
ILLINOIS STATE CANCER REgISTRy
Survey was established: 1) to obtain detailed information on dietary exposures
and to update with additional exposure information, and 2) to conduct
prospective cancer incidence follow‐up in addition to mortality follow‐up. ISCR
performs a data linkage to validate self‐reported cancers as part of the ongoing
cancer incidence follow‐up for the survey. This study is performed and funded by
the American Cancer Society. www.cancer.org/research/researchtopreventcancer
Transplant Cancer Match Study
Cancer is a major adverse outcome of solid organ transplantation. The elevated
risk of cancer is largely due to immunosuppression. The Transplant Cancer
Match Study linked the U.S. solid organ transplant registry with state and
regional cancer registries to get an overview of the cancer risk in more than
175,000 transplant recipients of all organ types. The study was designed to
get a better understanding of cancer risk in transplant recipients to help
clarify the role of the immune system, infections, and other factors in the
development of malignancy, and to identify opportunities to improve
transplant safety. JAMA, November 2, 2011–Vol. 306, No. 17
Cancer Resources
Illinois Department of Public Health
Office of Women's Health
http://www.idph.state.il.us/about/
womenshealth/concern.htm
American Cancer Society
www.cancer.org
National Cancer Institute
www.cancer.gov
U.S. Centers for
Disease Control and Prevention
www.cdc.gov
Illinois Breast and
Cervical Cancer Program
http://www.cancerscreening.illinois.gov
Illinois Tobacco Quitline
www.quityes.org  1-866-QUIT-yES
The official Illinois state insect is the Monarch butterfly.
prepared by
Lori Koch
Lindsay Snodgrass
Tiefu Shen
Jayneece Bostwick
Suggested citation: Koch L, Snodgrass L, Shen T, Bostwick J. Cancer in Illinois 2013.
Illinois Department of Public Health, Springfield, Ill. June 2013.
All material in this publication is in the public domain and may be reproduced or
copied without permission; citation as to source, however, is appreciated.
The Illinois Department of Public Health, Illinois State Cancer Registry (ISCR), makes
the cancer incidence data available as a public service. Use of these data does not
constitute an endorsement of the user’s opinion or conclusions by the Department
and none should be inferred.
This publication would not have been possible without the assistance of the Illinois
State Cancer Registry staff, the personnel at the reporting facilities who diagnose or
treat cancer patients throughout Illinois, and the staff members at other state central
cancer registries with data exchange agreements.
This publication was supported, in part, by Cooperative Agreement Number 1US58DP0038883‐01 from the U.S. Centers
for Disease Control and Prevention (CDC) National Cancer Prevention and Control Program. The contents are solely
the responsibility of the authors and do not necessarily represent the official views of CDC.
Printed by Authority of the State of Illinois
P.O. #5114348 250 11/13
IOCI 14-0263